Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-23-012275
Filing Date
2023-04-14
Accepted
2023-04-14 15:46:22
Documents
58
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 917895
2 ex31-1.htm EX-31.1 11929
3 ex31-2.htm EX-31.2 11534
4 ex32-1.htm EX-32.1 7912
5 ex32-2.htm EX-32.2 7838
  Complete submission text file 0001493152-23-012275.txt   4516012

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogen-20220331.xsd EX-101.SCH 30639
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ogen-20220331_cal.xml EX-101.CAL 62578
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ogen-20220331_def.xml EX-101.DEF 143830
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogen-20220331_lab.xml EX-101.LAB 263473
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogen-20220331_pre.xml EX-101.PRE 244421
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 596172
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-32188 | Film No.: 23821003
SIC: 2834 Pharmaceutical Preparations